TY  - JOUR
AU  - Kruse, Clemens
AU  - Heinemann, Katharine
PY  - 2022
DA  - 2022/1/4
TI  - Facilitators and Barriers to the Adoption of Telemedicine During the First Year of COVID-19: Systematic Review
JO  - J Med Internet Res
SP  - e31752
VL  - 24
IS  - 1
KW  - telemedicine
KW  - pandemic
KW  - technology acceptance
KW  - COVID-19
KW  - digital health
KW  - telehealth
KW  - health policy
KW  - health care
AB  - Background: The virulent and unpredictable nature of COVID-19 combined with a change in reimbursement mechanisms both forced and enabled the rapid adoption of telemedicine around the world. Thus, it is important to now assess the effects of this rapid adoption and to determine whether the barriers to such adoption are the same today as they were under prepandemic conditions. Objective: The objective of this systematic literature review was to examine the research literature published during the COVID-19 pandemic to identify facilitators, barriers, and associated medical outcomes as a result of adopting telemedicine, and to determine if changes have occurred in the industry during this time. Methods: The systematic review was performed in accordance with the Kruse protocol and the results are reported in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. We analyzed 46 research articles from five continents published during the first year of the COVID-19 pandemic that were retrieved from searches in four research databases: PubMed (MEDLINE), CINAHL, Science Direct, and Web of Science. Results: Reviewers identified 25 facilitator themes and observations, 12 barrier themes and observations, and 14 results (compared to a control group) themes and observations. Overall, 22% of the articles analyzed reported strong satisfaction or satisfaction (zero reported a decline in satisfaction), 27% reported an improvement in administrative or efficiency results (as compared with a control group), 14% reported no statistically significant difference from the control group, and 40% and 10% reported an improvement or no statistically significant difference in medical outcomes using the telemedicine modality over the control group, respectively. Conclusions: The pandemic encouraged rapid adoption of telemedicine, which also encouraged practices to adopt the modality regardless of the challenges identified in previous research. Several barriers remain for health policymakers to address; however, health care administrators can feel confident in the modality as the evidence largely shows that it is safe, effective, and widely accepted. 
SN  - 1438-8871
UR  - https://www.jmir.org/2022/1/e31752
UR  - https://doi.org/10.2196/31752
UR  - http://www.ncbi.nlm.nih.gov/pubmed/34854815
DO  - 10.2196/31752
ID  - info:doi/10.2196/31752
ER  -